<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35647070</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Sulodexide Significantly Improves Endothelial Dysfunction and Alleviates Chest Pain and Palpitations in Patients With Long-COVID-19: Insights From TUN-EndCOV Study.</ArticleTitle><Pagination><StartPage>866113</StartPage><MedlinePgn>866113</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">866113</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2022.866113</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">Non-respiratory long-coronavirus disease 2019 (COVID-19) symptoms are mainly related to a long-lasting endothelial dysfunction and microcirculation impairment. We hypothesized that Sulodexide, a purified glycosaminoglycan mixture with a beneficial endothelial effect in arterial and venous peripheral diseases, may be effective in a subset of patients with long COVID-19.</AbstractText><AbstractText Label="APPROACH AND RESULTS" NlmCategory="UNASSIGNED">We conducted a multicenter prospective quasi-experimental study. A total of 290 patients from the TUN-EndCOV study with long-COVID-19 symptoms and endothelial dysfunction were included. The endothelial function was clinically assessed using a post-occlusive reactive hyperemia protocol with finger thermal monitoring device. Endothelial quality index (EQI) was assessed at inclusion and at 21 days later. The study population was assigned to a sulodexide group (144 patients) or a no-medical treatment group (146 patients). Clinical characteristics were similar at inclusion in the two groups. Fatigue, shortness of breath, and chest pain were the most common symptoms, respectively, 54.5, 53.8, and 28.3%. At 21 days, the sulodexide group improved significantly better than the no-medical treatment group in chest pain (83.7 vs. 43.6%, <i>p</i> &lt; 10<sup>-3</sup>), palpitations (85.2 vs. 52.9%, <i>p</i> = 0.009), and endothelial function [median delta-EQI 0.66 (0.6) vs. 0.18 (0.3); <i>p</i> &lt; 10<sup>-3</sup>]. Endothelial function improvement was significantly correlated with chest pain and palpitations recovery (AUC, i.e., area under the curve = 0.66, CI [0.57- 0.75], <i>p</i> = 0.001 and AUC = 0.60, CI [0.51- 0.69], <i>p</i> = 0.03, respectively).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Sulodexide significantly improves long-lasting post-COVID-19 endothelial dysfunction and alleviates chest pain and palpitations.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Charfeddine, Ibnhadjamor, Jdidi, Torjmen, Kraiem, Bahloul, Makni, Kallel, Moussa, Boudaya, Touil, Ghrab, Elghoul, Meddeb, Thabet, Ben Salem, Addad, Bouslama, Milouchi, Hammami, Abdessalem and Abid.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Charfeddine</LastName><ForeName>Salma</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibnhadjamor</LastName><ForeName>Hassen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cardiology Department, Tahar Sfar Hospital, Mahdia, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jdidi</LastName><ForeName>Jihen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Preventive Medicine Department, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torjmen</LastName><ForeName>Slim</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pneumology Department, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraiem</LastName><ForeName>Salma</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiology Department, Tahar Sfar Hospital, Mahdia, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahloul</LastName><ForeName>Amine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makni</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kallel</LastName><ForeName>Nesrine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pneumology Department, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moussa</LastName><ForeName>Nedia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pneumology Department, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boudaya</LastName><ForeName>Mariem</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biochemistry Laboratory, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Touil</LastName><ForeName>Imen</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Pneumology Department, Tahar Sfar Hospital, Mahdia, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghrab</LastName><ForeName>Aiman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology Department, Habib Bourguiba Hospital Medenine, Medenine, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elghoul</LastName><ForeName>Jamel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pneumology Department, Habib Bourguiba Hospital Medenine, Medenine, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meddeb</LastName><ForeName>Zeineb</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Mongi Slim LaMarsa Hospital, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thabet</LastName><ForeName>Yamina</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Mongi Slim LaMarsa Hospital, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Salem</LastName><ForeName>Kais</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Private Doctor, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Addad</LastName><ForeName>Faouzi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Clinic Hannibal Tunis, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouslama</LastName><ForeName>Kamel</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Mongi Slim LaMarsa Hospital, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milouchi</LastName><ForeName>Sami</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology Department, Habib Bourguiba Hospital Medenine, Medenine, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammami</LastName><ForeName>Rania</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdessalem</LastName><ForeName>Salem</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinic Pasteur Tunis, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abid</LastName><ForeName>Leila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">endothelial dysfunction</Keyword><Keyword MajorTopicYN="N">long COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">microcirculation</Keyword><Keyword MajorTopicYN="N">sulodexide</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35647070</ArticleId><ArticleId IdType="pmc">PMC9133483</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2022.866113</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet Lond Engl. (2020) 395:497&#x2013;506. 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. . A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. (2020) 382:727&#x2013;33. 10.1056/NEJMoa2001017</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Johns Hopkins Coronavirus Resource Center . Available online at: https://coronavirus.jhu.edu/ (accessed August 2021).</Citation></Reference><Reference><Citation>Evans PC, Rainger GE, Mason JC, Guzik TJ, Osto E, Stamataki Z, et al. . Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res. (2020) 116:2177&#x2013;84. 10.1093/cvr/cvaa230</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa230</ArticleId><ArticleId IdType="pmc">PMC7454368</ArticleId><ArticleId IdType="pubmed">32750108</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy JH, Iba T, Gardiner EE. Endothelial Injury in COVID-19 and Acute Infections: Putting the Pieces of the Puzzle Together. Arterioscler Thromb Vasc Biol. (2021) 41:1774&#x2013;6. 10.1161/ATVBAHA.121.316101</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.121.316101</ArticleId><ArticleId IdType="pubmed">33792345</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe4;gele MP, Haubner B, Tanner FC, Ruschitzka F, Flammer AJ. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis. (2020) 314:58&#x2013;62. 10.1016/j.atherosclerosis.2020.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2020.10.014</ArticleId><ArticleId IdType="pmc">PMC7554490</ArticleId><ArticleId IdType="pubmed">33161318</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ.(2021) 372:n136. 10.1136/bmj.n136</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez&#x2013;Leon S, Wegman&#x2013;Ostrosky T, Perelman C, Sepulveda R, Rebolledo P, Cuapio A, et al. . More than 50 long&#x2013;term effects of COVID-19: a systematic review and meta&#x2013;analysis. Res Sq. (2021) 11:1&#x2013;2. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejia&#x2013;Renteria H, Travieso A, Sagir A, Mart&#xed;nez&#x2013;G&#xf3;mez E, Carrascosa-Granada A, Toya T, et al. . In&#x2013;vivo evidence of systemic endothelial vascular dysfunction in COVID-19. Int J Cardiol. (2021) 345:153&#x2013;5. 10.1016/j.ijcard.2021.10.140</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2021.10.140</ArticleId><ArticleId IdType="pmc">PMC8542397</ArticleId><ArticleId IdType="pubmed">34706286</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibn Hadj Amor H, Jdidi J, Torjmen S, Kraiem S, Hammami R, et al. . Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights From TUN-EndCOV study. Front Cardiovasc Med. (2021) 8:1702. 10.3389/fcvm.2021.745758</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao R&#x2013;N, Tang L, Xia Z&#x2013;Y, Xia R. Endothelial glycocalyx as a potential theriapeutic target in organ injuries. Chin Med J. (2019) 132:963&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6595754</ArticleId><ArticleId IdType="pubmed">30958439</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadosh BS, Garshick MS, Gaztanaga J, Moore KJ, Newman JD, Pillinger M, et al. . COVID-19 and the heart and vasculature: novel approaches to reduce virus&#x2013;induced inflammation in patients with cardiovascular disease. Arterioscler Thromb Vasc Biol. (2020) 40:2045&#x2013;53. 10.1161/ATVBAHA.120.314513</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.314513</ArticleId><ArticleId IdType="pmc">PMC7446967</ArticleId><ArticleId IdType="pubmed">32687400</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoppensteadt DA, Fareed J. Pharmacological profile of sulodexide. Int Angiol J Int Union Angiol. (2014) 33:229&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">24936531</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Ochoa AJ, Raffetto J, Hernandez Ibarra AG, Zavala N, Gutierrez O, Vargas A, et al. . Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial. Thromb Haemost. (2021) 121:944&#x2013;54. 10.1055/a-1414-5216</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1414-5216</ArticleId><ArticleId IdType="pubmed">33677827</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymath-Diagnose User Manual.pdf .</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M. A'Court C, Buxton M, Husain L. Management of post&#x2013;acute COVID-19 in primary care. BMJ. (2020) 370:m3026. 10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap J, Lim FY, Gao F, Teo LL, Lam CSP, Yeo KK. Correlation of the New York heart association classification and the 6&#x2013;minute walk distance: a systematic review. Clin Cardiol. (2015) 38:621&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6490728</ArticleId><ArticleId IdType="pubmed">26442458</ArticleId></ArticleIdList></Reference><Reference><Citation>Kos D, Kerckhofs E, Carrea I, Verza R, Ramos M, Jansa J. Evaluation of the Modified Fatigue Impact Scale in four different European countries. Mult Scler Houndmills Basingstoke Engl. (2005) 11:76&#x2013;80. 10.1191/1352458505ms1117oa</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1352458505ms1117oa</ArticleId><ArticleId IdType="pubmed">15732270</ArticleId></ArticleIdList></Reference><Reference><Citation>Pangman VC, Sloan J, Guse L. An examination of psychometric properties of the mini&#x2013;mental state examination and the standardized mini&#x2013;mental state examination: implications for clinical practice. Appl Nurs Res ANR. (2000) 13:209&#x2013;13. 10.1053/apnr.2000.9231</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/apnr.2000.9231</ArticleId><ArticleId IdType="pubmed">11078787</ArticleId></ArticleIdList></Reference><Reference><Citation>Calkins H. The 2019 ESC Guidelines for the Management of Patients with Supraventricular Tachycardia. Eur Heart J. (2019) 40:3812&#x2013;3. 10.1093/eurheartj/ehz837</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz837</ArticleId><ArticleId IdType="pubmed">31837143</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid: How to define it and how to manage it. BMJ.(2020) 370:m3489. 10.1136/bmj.m3489</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post&#x2013;acute COVID-19 syndrome. Nat Med. (2021) 27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit NM, Churchill A, Nsair A, Hsu JJ. Post&#x2013;Acute COVID-19 Syndrome and the cardiovascular system: What is known? Am Heart J Plus Cardiol Res Pract. (2021) 5:100025. 10.1016/j.ahjo.2021.100025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahjo.2021.100025</ArticleId><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="pubmed">34192289</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhmerov A, Marb&#xe1;n E. COVID-19 and the Heart. Circ Res. (2020) 126:1443&#x2013;55. 10.1161/CIRCRESAHA.120.317055</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317055</ArticleId><ArticleId IdType="pmc">PMC7188058</ArticleId><ArticleId IdType="pubmed">32252591</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. . Endothelial cell infection and endotheliitis in COVID-19. Lancet. (2020) 395:1417&#x2013;8. 10.1016/S0140-6736(20)30937-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, Akbari A, Inabadi M, Savardashtaki A, et al. . COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti Infect Ther. (2021) 19:345&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">32921216</ArticleId></ArticleIdList></Reference><Reference><Citation>Avolio E, Carrabba M, Milligan R, Kavanagh Williamson M, Beltrami AP, Gupta K, et al. . The SARS&#x2013;CoV&#x2212;2 Spike protein disrupts human cardiac pericytes function through CD147 receptor&#x2013;mediated signalling: a potential non&#x2013;infective mechanism of COVID-19 microvascular disease. Clin Sci Lond Engl. (2021) 135:2667&#x2013;89. 10.1042/CS20210735</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20210735</ArticleId><ArticleId IdType="pmc">PMC8674568</ArticleId><ArticleId IdType="pubmed">34807265</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox SE, Li G, Akmatbekov A, Harbert JL, Lameira FS, Brown JQ, et al. . Unexpected Features of Cardiac Pathology in COVID-19 Infection. Circulation. (2020) 142:1123&#x2013;5. 10.1161/CIRCULATIONAHA.120.049465</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.049465</ArticleId><ArticleId IdType="pubmed">32689809</ArticleId></ArticleIdList></Reference><Reference><Citation>Camaz&#xf3;n NV, Teis A, Membrive MJM, Llibre C, Bay&#xe9;s&#x2013;Gen&#xed;s A, Mateu L. Long COVID-19 and microvascular disease&#x2013;related angina. Rev Esp Cardiol. (2021) 142:1123&#x2013;1125.</Citation></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. . Autonomic dysfunction in &#x226a; long COVID &#x226b;: rationale, physiology and management strategies. Clin Med Lond Engl. (2021) 21:e63&#x2013;7. 10.7861/clinmed.2020-0896</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. . Post&#x2013;covid syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ.(2021) 372:n693. 10.1136/bmj.n693</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Liu S. Proposed subtypes of post-COVID-19 syndrome (or long&#x2013;COVID) and their respective potential therapies. Rev Med Virol. (2021) e2315. 10.1002/rmv.2315 [Online ahead of print].</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>du Preez HN, Aldous C, Hayden MR, Kruger HG, Lin J. Pathogenesis of COVID-19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx. FASEB J Off Publ Fed Am Soc Exp Biol. (2022) 36:e22052. 10.1096/fj.202101100RR</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202101100RR</ArticleId><ArticleId IdType="pubmed">34862979</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollenberg R, Tepasse P&#x2013;R, Ochs K, Floer M, Strauss M, Rennebaum F, et al. . Indications of persistent glycocalyx damage in convalescent COVID-19 patients: a prospective multicenter study and hypothesis. Viruses. (2021) 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8619155</ArticleId><ArticleId IdType="pubmed">34835130</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, et al. . Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost JTH. (2021) 19:2546&#x2013;53. 10.1111/jth.15490</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen D, Chen R, Zhang L, Rao Z, Ruan Y, Li L, et al. . Sulodexide attenuates endoplasmic reticulum stress induced by myocardial ischaemia/reperfusion by activating the PI3K/Akt pathway. J Cell Mol Med. (2019) 23:5063&#x2013;75. 10.1111/jcmm.14367</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.14367</ArticleId><ArticleId IdType="pmc">PMC6653332</ArticleId><ArticleId IdType="pubmed">31120192</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogn&#xe9; S, Flamion B, Caron N. Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases. Arterioscler Thromb Vasc Biol. (2018) 38:1427&#x2013;39. 10.1161/ATVBAHA.118.310839</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.118.310839</ArticleId><ArticleId IdType="pmc">PMC6039403</ArticleId><ArticleId IdType="pubmed">29880486</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasierra&#x2013;Cirujeda J, Coronel P, Aza M, Gimeno M. Use of sulodexide in patients with peripheral vascular disease. J Blood Med. (2010) 1:105&#x2013;15. 10.2147/JBM.S10558</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JBM.S10558</ArticleId><ArticleId IdType="pmc">PMC3262318</ArticleId><ArticleId IdType="pubmed">22282689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauver DA, Lucchesi BR. Sulodexide: a renewed interest in this glycosaminoglycan. Cardiovasc Drug Rev. (2006) 24:214&#x2013;26. 10.1111/j.1527-3466.2006.00214.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1527-3466.2006.00214.x</ArticleId><ArticleId IdType="pubmed">17214598</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauro M, Palmieri GC, Palazzini E, Barbanti M, Calanni Rindina F, Milani MR. Pharmacodynamic effects of single and repeated doses of oral sulodexide in healthy volunteers. A placebo&#x2013;controlled study with an enteric&#x2013;coated formulation. Curr Med Res Opin. (1993) 13:87&#x2013;95. 10.1185/03007999309111537</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/03007999309111537</ArticleId><ArticleId IdType="pubmed">8325046</ArticleId></ArticleIdList></Reference><Reference><Citation>Femiano F, Gombos F, Scully C. Recurrent aphthous stomatitis unresponsive to topical corticosteroids: a study of the comparative therapeutic effects of systemic prednisone and systemic sulodexide. Int J Dermatol. (2003) 42:394&#x2013;7. 10.1046/j.1365-4362.2003.01853.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-4362.2003.01853.x</ArticleId><ArticleId IdType="pubmed">12755982</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska M, Wolszakiewicz J, Duda M, Janas J, Beresewicz A, Piotrowicz R. Antioxidative activity of sulodexide, a glycosaminoglycan, in patients with stable coronary artery disease: a pilot study. Med Sci Monit Int Med J Exp Clin Res d&#xe9;c. (2009) 15:CR618&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pubmed">19946232</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B, Chatterjee S, Kirtane AJ, Parikh SA, Andreozzi GM, Desai NR, et al. . Sulodexide versus control and the risk of thrombotic and hemorrhagic events: meta&#x2013;analysis of randomized trials. Semin Thromb Hemost. (2020) 46:908&#x2013;18. 10.1055/s-0040-1716874</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1716874</ArticleId><ArticleId IdType="pubmed">33086402</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Q&#x2013;J, Bai J, Jin J, Shi J, Qu L. Sulodexide for secondary prevention of recurrent venous thromboembolism: a systematic review and meta&#x2013;analysis. Front Pharmacol. (2018) 9:876. 10.3389/fphar.2018.00876</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00876</ArticleId><ArticleId IdType="pmc">PMC6092709</ArticleId><ArticleId IdType="pubmed">30135652</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, et al. . Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research. Thromb Haemost. (2020) 120:1004&#x2013;24. 10.1055/s-0040-1713152</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1713152</ArticleId><ArticleId IdType="pmc">PMC7516364</ArticleId><ArticleId IdType="pubmed">32473596</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnani HN. Rationale for the role of heparin and related GAG antithrombotics in COVID-19 infection. Clin Appl Thromb Off J Int Acad Clin Appl Thromb. (2021) 27:1076029620977702. 10.1177/1076029620977702</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029620977702</ArticleId><ArticleId IdType="pmc">PMC7868468</ArticleId><ArticleId IdType="pubmed">33539214</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>